Table. V.
Hazard ratio (HR) of death for indicator not fulfilled vs. fulfilled. The adjusted model includes gender, age, Charlson index and tumour site as covariates.
| Indicator | Unadjusted model | Adjusted model | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | ||||
| S1 | Interval between cyto-histological assessment and surgery as the first treatment ≤ 60 days | 0.99 | 0.64 | 1.54 | 0.97 | 0.62 | 1.51 |
| S2 | Interval between cyto-histological assessment and RT as the first treatment ≤ 60 days | 1.57 | 1.05 | 2.34 | 1.25 | 0.81 | 1.92 |
| S3 | Interval between discharge from primary surgery and postoperative RT ≤ 60 days | 0.81 | 0.55 | 1.19 | 0.79 | 0.53 | 1.18 |
| S4 | Interval between cyto-histological assessment and CT as the first treatment ≤ 60 days | 1.01 | 0.31 | 3.36 | 0.70 | 0.20 | 2.43 |
| D1 | Having performed a cyto-histological assessment of the primary tumour in the 180 days before the first treatment | 1.01 | 0.80 | 1.26 | 1.00 | 0.80 | 1.27 |
| D2* | With distant metastasis risk tumour type undergoing systemic staging with PET-CT or whole body computed tomography | 0.97 | 0.68 | 1.38 | 0.93 | 0.65 | 1.33 |
| T2 | With a second hospital access ≤ 30 days from discharge for primary surgery | 1.01 | 0.76 | 1.34 | 0.99 | 0.74 | 1.32 |
| T3 | Treated with IMRT | 1.26 | 0.99 | 1.59 | 1.20 | 0.94 | 1.54 |
*not adjusted for tumour site.
Abbreviations: HR = hazard ratio, CI: = confidence interval.